Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals

A study published in the journal Nutrition & Diabetes reveals that increasing the intake of flavonoid-rich foods can reduce the risk of developing type 2 diabetes.

Study: Higher habitual intakes of flavonoids and flavonoid-rich foods are associated with a lower incidence of type 2 diabetes in the UK Biobank cohort. Image Credit: DIVA.photo / ShutterstockStudy: Higher habitual intakes of flavonoids and flavonoid-rich foods are associated with a lower incidence of type 2 diabetes in the UK Biobank cohort. Image Credit: DIVA.photo / Shutterstock


Type 2 diabetes has become a significant public health concern because of its steadily increasing prevalence worldwide. Currently, 415 million people are living with diabetes, and more than 4 million deaths are associated with this condition globally.

Certain modifiable risk factors, such as obesity and overweight, are associated with the development of type 2 diabetes, which subsequently increases the risk of developing several health complications, including cardiovascular disease, kidney disease, dementia, and certain cancer types.    

A higher intake of plant-based diet is known to reduce the risk of type 2 diabetes. Plants are rich sources of various polyphenolic compounds with different bioavailability and bioactivity. Flavonoids are a class of polyphenolic compounds grouped into six main subclasses: flavanones, flavones, flavan-3-ols, flavonols, anthocyanins, and isoflavones.

Evidence from randomized controlled trials (RCTs) indicates that higher intake of flavonoids is associated with increased insulin sensitivity, reduced insulin resistance, and improved blood lipid profile.

In this study, scientists have investigated the association between a flavonoid-rich diet and incident type 2 diabetes in a large-scale UK population.

Study design

A total of 113,097 UK Biobank participants were enrolled in the study. The UK Biobank is a large-scale, population-based prospective cohort study of more than 500,000 adult participants recruited from the UK between 2006 and 2010.

Two or more 24-hour dietary assessments obtained from the participants were analyzed using the US Department of Agriculture databases to calculate flavonoid intakes. Ten flavonoid-rich food items were selected based on mean daily intakes (daily servings). A Flavodiet Score (FDS) was calculated by summing the total number of servings consumed across the ten selected food items.   

Appropriate statistical analyses were conducted considering potential confounding factors to determine the association between dietary exposures and incident type 2 diabetes.

Important observations

During the average study follow-up period of 12 years, 2,628 incident type 2 diabetes cases were identified.

A comparatively higher intake of flavonoid-rich diet was observed among female participants, older participants, physically active participants, or those with higher educational backgrounds.

The average total flavonoid intake per day was 805.7 milligrams. Among different subclasses, polymers, including proanthocyanidins and flavan-3-ols, contributed 67% and 22% of total flavonoid intake, respectively. Tea intake was the primary source for these two subclasses.

The lowest contributing subclass to total flavonoids was flavones, derived predominantly from peppers.

Association between flavonoid intake and incident type 2 diabetes risk

The analysis adjusted for demographic and lifestyle characteristics of participants revealed that a higher FDS (six servings of flavonoid-rich foods per day) is associated with a 28% lower risk of incident type 2 diabetes, as compared to lower FDS (one serving of flavonoid-rich foods per day). 

The dose-response analysis revealed that increasing one serving per day of flavonoid-rich foods is associated with a 6% lower risk of incident diabetes.

Regarding specific flavonoid-rich food items, the study found that higher intakes of black or green tea, berries, and apples are associated with 21%, 15%, and 12% lower risk of incident type 2 diabetes, respectively.

Regarding specific flavonoid subclasses, higher intakes of anthocyanins, flavan-3-ols, flavonols, flavones, polymers, and proanthocyanidins were found to associate with a 19%, 26%, 28%, 19%, 26%, and 27% lower risk of incident diabetes, respectively.

Mechanistic analysis

The study analyzed several potential biomarkers related to type 2 diabetes to identify the biological mechanisms responsible for the observed associations.

The mediation analysis identified body mass index (BMI), insulin-like growth factor 1 (IGF-1), C-reactive protein, cystatin C, urate, gamma-glutamyl transferase (GGT), and alanine aminotransferase (ALT) as potential mediators.

Specifically, the findings indicated that the beneficial effects of a flavonoid-rich diet on body weight management, glucose metabolism, basal inflammation, and kidney and liver functions are partly responsible for the reduction in type 2 diabetes risk observed in the study.

Study significance

The study finds that flavonoid-rich foods can significantly reduce the risk of type 2 diabetes by regulating obesity, glucose metabolism, inflammation, kidney function, and liver function.

Existing literature indicates that flavonoids, especially anthocyanins, flavan-3-ols, and flavonols, can exert anti-diabetic effects by improving insulin secretion and signaling and facilitating glucose transportation and metabolism.

As mentioned by the scientists, the study population includes middle-aged British adults, which restricts the generalizability of findings to other non-European populations.

Overall, this study supports the current recommendation to increase the intake of fruits, especially berries and apples, to reduce type 2 diabetes risk.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2024, May 23). Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals. News-Medical. Retrieved on June 22, 2024 from https://www.news-medical.net/news/20240523/Flavonoid-rich-diet-slashes-type-2-diabetes-risk-by-up-to-2825-new-study-reveals.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals". News-Medical. 22 June 2024. <https://www.news-medical.net/news/20240523/Flavonoid-rich-diet-slashes-type-2-diabetes-risk-by-up-to-2825-new-study-reveals.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals". News-Medical. https://www.news-medical.net/news/20240523/Flavonoid-rich-diet-slashes-type-2-diabetes-risk-by-up-to-2825-new-study-reveals.aspx. (accessed June 22, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2024. Flavonoid-rich diet slashes type 2 diabetes risk by up to 28%, new study reveals. News-Medical, viewed 22 June 2024, https://www.news-medical.net/news/20240523/Flavonoid-rich-diet-slashes-type-2-diabetes-risk-by-up-to-2825-new-study-reveals.aspx.


  1. Your mom Your mom United States says:

    Meanwhile, in reality, reducing carbs by eating keto or even carnivore will eliminate most diabetes and get you completely off meds.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Safety-focused summary of GLP-1 receptor agonists in diabetes, obesity, and beyond